Two patients with a co-occurring EGFR-TP53-RB1 alteration, predisposing to transformation to small cell carcinoma or squamous cell carcinoma following EGFR TKI treatment [27,28], were observed. This evidence concerns the gene TP53 and squamous cell carcinoma.